Issues around Paxlovid – Part 2

This episode continues our discussion on the important new COVID treatment Paxlovid. Covered in this program are issues such as resistance, drug-to-drug interactions, the recommended course of treatment and impact on patient care.

 

Guest speaker:
Stacy Lauderdale, PharmD, BCPS
Senior Director, Drug Information
Vizient

 

Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Principal, Clinical Operations and Quality
Vizient

 

Show Notes:

[00:49] Resistance to Paxlovid

[01:38] Patient candidates for Paxlovid

[03:09] Contraindications and drug interactions

[02:47] Whether or not to get flu vaccines

[06:00] Latest studies/trials

[07:04] Prescribing issues

[08:43] “Paxlovid Mouth”

[09:10] Stop dispensing Paxlovid like Pez

 

Links | Resources:

To contact Modern Practice: modernpracticepodcast@vizientinc.com

Stacy’s email address: stacy.lauderdale@vizientinc.com

13 Things to Know about Paxlovid, the Latest COVID-19 Pill (Yale Medicine) Click here

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Android

Google Podcasts

Spotify

Stitcher

RSS Feed